title: Nanoparticle-induced tight-junction opening for the transport of an anti-angiogenic sulfated polysaccharide across Caco-2 cell monolayers.
abstract: Fucoidan has the ability to inhibit angiogenesis by human umbilical vein endothelial cells (HUVECs). However, a major clinical limitation is its poor oral availability because fucoidan is a hydrophilic macromolecule. In this study, an oversulfation reaction of fucoidan has been performed to enhance its anti-angiogenic activities. The synthesized, oversulfated fucoidan (OFD) was characterized by Fourier transform infrared spectroscopy. The oversulfate content of OFD was estimated to be 41.7% by using a BaCl2 gelatin method. Nanoparticles (NPs) composed of chitosan (CS) and OFD were prepared by a polycation-polyanion complex method. The mean particle sizes of prepared CS/OFD NPs were in the range of 172-265nm with a negative or positive surface charge, depending on the relative concentrations of CS to OFD used. The self-assembled NPs with pH-sensitive characteristics could be used as a pH-switched nanocarrier for oral delivery of the antiangiogenic macromolecule, OFD, in response to simulated gastrointestinal (GI) tract media. Evaluation of test NPs in enhancing the intestinal paracellular transport of OFD suggested that the NPs with a positive surface charge could transiently open the tight junctions between Caco-2 cells and thus increase the paracellular permeability. Tight-junction opening and restoration were examined by monitoring the redistribution of ZO-1 tight-junction proteins using confocal laser scanning microscopy (CLSM). The transported OFD significantly inhibits the tube formation of HUVECs via competitive binding of OFD and basic fibroblast growth factor (bFGF) to bFGF receptors (bFGFRs).
authors.affiliation: Department of Materials Science and Engineering, Vanung University, Chung-Li, Taiwan, ROC.
authors.forename: Shu-Huei
authors.initials: SH
authors.lastname: Yu
authors.forename: Deh-Wei
authors.initials: DW
authors.lastname: Tang
authors.forename: Hao-Ying
authors.initials: HY
authors.lastname: Hsieh
authors.forename: Wen-Shin
authors.initials: WS
authors.lastname: Wu
authors.forename: Bo-Xian
authors.initials: BX
authors.lastname: Lin
authors.forename: Er-Yuan
authors.initials: EY
authors.lastname: Chuang
authors.forename: Hsing-Wen
authors.initials: HW
authors.lastname: Sung
authors.forename: Fwu-Long
authors.initials: FL
authors.lastname: Mi
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000737:chemistry; D018938:Caco-2 Cells; D002470:Cell Survival / Q000187:drug effects; D042783:Endothelial Cells / Q000166:cytology / Q000187:drug effects*; D006801:Humans; D053769:Nanocapsules / Q000008:administration & dosage* / Q000737:chemistry* / Q000648:ultrastructure; D011134:Polysaccharides / Q000008:administration & dosage* / Q000737:chemistry*; D019108:Tight Junctions / Q000737:chemistry* / Q000187:drug effects*
chemical_list: D020533:Angiogenesis Inhibitors; D053769:Nanocapsules; D011134:Polysaccharides; C007789:fucoidan